Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines (Q37149005)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3384914%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

title

Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3384914%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference

1 reference

influenza A virus

1 reference

R B Belshe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3384914%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

G J Gorse

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3384914%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

N J Munn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3384914%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

language of work or name

English

0 references

publication date

1 May 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3384914%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Microbiology

24 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3384914%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3384914%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3384914%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

911-918

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3384914%20AND%20SRC:MED&resulttype=core&format=json

Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses

24 September 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Antibody response to inactivated influenza vaccine given by different routes in patients with chronic bronchopulmonary disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Viral vaccination via the mucosal routes.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Responses of elderly subjects to a new subunit influenza virus vaccine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Live attenuated influenza A virus vaccines in children: results of a field trial

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Failure of inactivated influenza vaccine to protect an aged population

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Age-dependent antibody response in mice and humans following oral influenza immunization

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Effects of vaccination on an influenza epidemic in a geriatric hospital

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Attenuated influenza produced by experimental intranasal inoculation

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic stra

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Dose response of cold-adapted, reassortant influenza A/California/10/78 virus (H1N1) in adult volunteers

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Dose response of influenza A/Washington/897/80 (H3N2) cold-adapted reassortant virus in adult volunteers

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Cold-recombinant influenza A/California/10/78 (H1N1) virus vaccine (CR-37) in seronegative children: infectivity and efficacy against investigational challenge

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Immune response of adults to sequential influenza vaccination

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=266485

Influenza vaccination of elderly persons. Reduction in pneumonia and influenza hospitalizations and deaths

3 September 2018

1 reference

12 December 2020

A/USSR and B/Hong Kong vaccine. Field experiences during an A/Brazil and an influenza B epidemic

1 reference

12 December 2020

Responses of elderly subjects to monovalent A/USSR/77 (H1N1) and Trivalent A/USSR/77 (H1N1)-A/TEXAS/77 (H3N2)-B/Hong Kong/72 vaccines

1 reference

12 December 2020

Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic

1 reference

12 December 2020

Influenza subunit vaccine: antibody responses to one and two doses of vaccine and length of response, with particular reference to the elderly

1 reference

12 December 2020